Innoviva, Inc. (INVA)
23.39
-0.25
(-1.06%)
USD |
NASDAQ |
Feb 20, 16:00
23.38
0.00 (0.00%)
After-Hours: 20:00
Innoviva EPS Diluted (Quarterly) : 1.082 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 1.191 |
| Nektar Therapeutics | -1.875 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Oramed Pharmaceuticals, Inc. | 1.131 |
| Theravance Biopharma, Inc. | 0.0696 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 89.91M |
| Revenue (Quarterly) | 111.26M |
| Total Expenses (Quarterly) | 21.35M |
| Enterprise Value | 1.475B |
| Gross Profit Margin (Quarterly) | 67.87% |
| Profit Margin (Quarterly) | 80.81% |
| Earnings Yield | 5.96% |
| Operating Earnings Yield | 9.08% |
| Normalized Earnings Yield | 7.363 |